Cullinan Therapeutics, Inc. (CGEM) — Analyst estimates
Consensus analyst estimates for Cullinan Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 17.95M | -0.6 | 3 |
| 2027 | 52.39M | -0.57 | 2 |
| 2028 | 0 | -0.98 | 5 |
| 2029 | 69.73M | -2.9 | 2 |
| 2030 | 228.55M | -1.63 | 5 |
Consensus analyst estimates by fiscal year.